Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia

NCT02652793 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Boosted atazanavir
DRUG: Lamivudine

Sponsor

Judit Pich

Collaborators

[object Object]